Earlier this month, we updated on the Food and Drug Administration’s efforts to mitigate ongoing IV saline shortages that resulted from, or were worsened by, the devastating impact of Hurricane María in Puerto Rico. We also provided some additional updates related to our continued efforts to help the island fully recover from this disaster.
As we enter the new year and pass the 100-day mark from when Hurricane María made landfall in Puerto Rico, we want to provide an update on the current recovery efforts, the state of existing drug shortages that resulted from the impact of the storm and our continued commitment to help the island fully recover.
Baxter International Inc. said Thursday while it is anticipating a reduction in revenue for fourth quarter 2017 as a result of Hurricane María, it expects to “mitigate the related earnings impact through positive performance in other areas of the business.”